Mukherjee, A. (2026). Analytical dissection of CRISPR-Cas9-mediated gene editing fidelity: Integrating next-generation bioanalytical platforms for precision immunotherapeutics and rare disease correction. Journal of Rare Diseases, 5(1), 1. https://doi.org/10.1007/s44162-026-00220-3
Chicago Style (17th ed.) CitationMukherjee, Arpita. "Analytical Dissection of CRISPR-Cas9-mediated Gene Editing Fidelity: Integrating Next-generation Bioanalytical Platforms for Precision Immunotherapeutics and Rare Disease Correction." Journal of Rare Diseases 5, no. 1 (2026): 1. https://doi.org/10.1007/s44162-026-00220-3.
MLA (9th ed.) CitationMukherjee, Arpita. "Analytical Dissection of CRISPR-Cas9-mediated Gene Editing Fidelity: Integrating Next-generation Bioanalytical Platforms for Precision Immunotherapeutics and Rare Disease Correction." Journal of Rare Diseases, vol. 5, no. 1, 2026, p. 1, https://doi.org/10.1007/s44162-026-00220-3.